Colony-stimulating factor-1 receptor provides a growth advantage in epithelial cancer cell line A431 in the presence of epidermal growth factor receptor inhibitor gefitinib - Niehus, S E; Tran, D DH; Mischak, M; Koch, A (Cell Signal, 2018)